# The Combination Effect of Statin Plus Metformin on Relapse-free

> **NCT02819869** · PHASE2 · TERMINATED · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 3 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Statin and Metformin use

## Key facts

- **NCT ID:** NCT02819869
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-01
- **Primary completion:** 2016-09-01
- **Final completion:** 2016-12-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** insufficient for the fund
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02819869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02819869, "The Combination Effect of Statin Plus Metformin on Relapse-free". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02819869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*